Table 2 Tumor entities assigned by anatomical region
Tumor entities: N (%) | |
|---|---|
Pelvic malignancies | 46 (59.7) |
 Carcinoma of the cervix | 19 (24.7) |
 Endometrioid carcinoma | 9 (11.7) |
 Prostate carcinoma | 4 (5.2) |
 Bladder carcinoma | 3 (3.9) |
 Rectum carcinoma | 3 (3.9) |
 Ureter carcinoma | 3 (3.9) |
 Ovarial carcinoma | 2 (2.6) |
 Uterus sarcoma | 1 (1.3) |
 Anal carcinoma | 1 (1.3) |
 Pelvic CUP | 1 (1.3) |
Thoracic malignancies | 19 (24.7) |
 Non-small cell lung cancer | 13 (16.9) |
 Breast carcinoma | 3 (3.9) |
 Esophageal carcinoma | 1 (1.3) |
 Small cell lung cancer | 1 (1.3) |
Abdominal malignancies | 7 (9.1) |
 Colon carcinoma | 2 (2.6) |
 Renal cell carcinoma | 3 (3.9) |
 Gastric carcinoma | 1 (1.3) |
 Liposarcoma | 1 (1.3) |
 Pancreatic carcinoma | 1 (1.3) |
Head and neck malignancies | 3 (3.9) |
 Hypopharynx carcinoma | 1 (1.3) |
 Carcinoma of the tongue | 1 (1.3) |
 Oropharynx carcinoma | 1 (1.3) |
Skin cancer | 2 (2.6) |
 Malignant melanoma | 2 (2.6) |